Janus Henderson Group’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-17,756
Closed -$353K 2749
2023
Q1
$353K Buy
+17,756
New +$307K ﹤0.01% 2208
2021
Q4
Sell
-1,525,123
Closed -$50.1M 2604
2021
Q3
$50.1M Sell
1,525,123
-79,863
-5% -$2.98M 0.02% 549
2021
Q2
$68.5M Buy
1,604,986
+235,986
+17% +$9.23M 0.03% 479
2021
Q1
$52.5M Sell
1,369,000
-311
-0% -$13.2K 0.02% 536
2020
Q4
$59.9M Buy
1,369,311
+11,610
+0.9% +$437K 0.03% 493
2020
Q3
$53.4M Sell
1,357,701
-9,023
-0.7% -$291K 0.03% 484
2020
Q2
$43.1M Buy
1,366,724
+12,858
+0.9% +$480K 0.02% 523
2020
Q1
$47.7M Buy
1,353,866
+813,837
+151% +$34.3M 0.03% 470
2019
Q4
$26.2M Buy
540,029
+535,085
+10,823% +$24.4M 0.01% 756
2019
Q3
$235K Buy
4,944
+36
+0.7% +$1.69K ﹤0.01% 1365
2019
Q2
$211K Sell
4,908
-1,086
-18% -$42.2K ﹤0.01% 1347
2019
Q1
$232K Buy
+5,994
New +$203K ﹤0.01% 1315
2018
Q4
Sell
-5,170
Closed -$202K 1443
2018
Q3
$202K Buy
+5,170
New +$191K ﹤0.01% 1427

Other funds holding CSII

Janus Henderson Group's CSII Position: Q2 2023 in Review

Janus Henderson Group sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 17,756 shares — an estimated $353K sold.

Janus Henderson Group first reported a position in CSII in Q3 2018 and held it in 13 quarters. The position peaked at $68.5M in Q2 2021. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

  • Janus Henderson Group reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
  • Janus Henderson Group sold 17,756 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $353K.
  • Janus Henderson Group first reported a position in Cardiovascular Systems, Inc. in Q3 2018 and held it in 13 quarters.
  • Janus Henderson Group's Cardiovascular Systems, Inc. position peaked at $68.5M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Janus Henderson Group's 13F filing for Q2 2023, filed 14 Aug 2023.